11.05.2011BioForum 2011 - Central European Forum of Biotechnology and Innovative BioEconomyYou are hereEventsLife science events BioForum 2011 - Central European Forum of Biotechnology and Innovative BioEconomy
BioForum - Central European Forum of Biotechnology and Innovative BioEconomy is the biggest and the most important international event for biotechnology in the region of Central Europe
The main goal of BioForum is to create business networking between growing Central European and well-established US as well as Western European biobusiness. It is an event supporting technology transfer from life sciences (biotechnology, biochemistry, molecular biology, etc.) to areas such as bioeconomy, health, drugs and food production, cosmetics and environment. BioForum visitors are given a unique possibility to drive into sea of valuable, applicable R&D projects gathered in one place at the same time.
BioForum is not only an opportunity for Central Europe to become the source of innovative biotechnologies, but also a chance for world biotechnology leaders to find new products in this region. As it gathers the trade fair and B2B meetings in one place at the same time, it provides the biotech industry with opportunities to exchange information, experience and business contacts, which will eventually lead to profitable ventures and generate “value-added” to this highly knowledge based sector of the economy.
The results of the 9th edition of BioForum (19-21th May 2010) once again superseded the expectations of the event organisers. More than 1500 participants – representing 20 countries, 100 exhibitors, over 100 R&D projects presented, more than 900 business meetings within the frames of BioPartnering – these are only some of the results of last edition of BioForum. Different levels of the single business event in the biotechnology and life-science sector proved to be attractive for the participants: the exhibition and poster sessions, high-profile presentations, seminars and workshops, BioPartnering – business meetings, high-profile conference „The economical effects of Biotechnology Development in the regions” and the much-frequented Jobvector Career Day.
Le Challenge Debiopharm InartisLa qualité de vie du patient en cours de traitement "Qui pourra changer le monde dans lequel nous vivons?”
DFB Pharmaceuticals Inc.Medical Devices, Consumables & ReagentsSummary of activity
DFB BioScience's primary focus is in the field of Cell Biology and Cell based therapies. The company develops Cell based therapies for treating chronic and acute wounds. Our R&D program includes several products at different development stage (preclinical, clinical, market approval). DFB BioScience can also provide manufacturing services for cell banking and Cell based products clinical manufacturing.
DFB BioScience is one of DFB Pharmaceuticals’ International branches. DFB Pharmaceuticals Inc., the mother company, is a fully integrated pharmaceutical group composed of two main divisions, DPT Laboratories, a Contract Manufacturing Organization providing customers with drug development and manufacturing services, and Healthpoint, which develops & markets pharmaceutical and medical products for chronic wounds.